Skip to main content
Equibles
RDNT logo

RDNT · RadNet, Inc.

Track RDNT — free

Use RDNT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RDNT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$75.54 +1.71 (+2.32%) At close · Aug 19
Market Cap
$5.87B
Shares
78.70M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$75.54 Open$75.07 Day$74.62–76.56 52W close$51.87–84.48 Avg vol 30d732K Short int10.4M · 13.2% float · 16.9d Short vol76% Last earningsAug 10, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Strong Sentiment Bearish Fundamentals Strong Quant / Vol Moderate
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +14%
      above
      Price vs 50-day avg +18%
      above
      RSI (14) 65
      neutral
      MACD trend Positive
      52-week position 73%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return +28%
      trailing
      6-month return +5%
      trailing
      YTD return +6%
      this year
      Relative strength −7%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $64 › 200d $66 — 200d above 50d
      Institutional flow Distributing
      -4% holders QoQ · +41 funds added
      Insider flow Distributing
      Net -$3.0M over 90 days · 100% sells
      Short interest Rising
      13.25% of float · ▲ +3.9% MoM · 16.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      330 holders — mid 3-yr range
      Squeeze score 87
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +13%
      Y/Y
      EPS growth −725%
      Y/Y
      Free cash flow $224.7M
      Balance sheet $157.5M
      net cash
      Quant / Vol
      risk profile
      Moderate
      Volatility 42%
      annualized · 1-yr
      Max drawdown −39%
      past year
      ATR 4.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 11, 2026
      Imaging Center Segment Total Net Revenue · full-year 2026 $2.36B – $2.41B
      Digital Health Segment Total Net Revenue · full-year 2026 $135M – $145M
      Digital Health Segment Non-Capitalized R&D - DeepHealth Cloud OS · full-year 2026 $17M – $19M
      Digital Health Segment Capital Expenditures · full-year 2026 $9M – $12M
      Prior guidance period ended · from the 8-K filed Nov 10, 2025
      Adjusted EBITDA · full-year 2025 $276M – $284M
      Cash Interest Expense · full-year 2025 $31M – $36M
      Capital Expenditures · full-year 2025 $157M – $167M
      Free Cash Flow Before Non-Capitalized R&D - DeepHealth Cloud OS · full-year 2025 $10M – $12M
      Free Cash Flow · full-year 2025 $70M – $80M
      Guided vs delivered · last 1 settled
      Total net revenue 2023
      guided $1.58B – $1.61B
      $1.62B Beat +1.5%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 4 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +14% Bullish
      Price vs 50-day avg
      +18% Bullish
      RSI (14)
      65 Neutral
      MACD trend
      Positive Bullish
      52-week position
      73% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 3 of 6
      Trend (MA cross) No cross
      50d $64 › 200d $66 — 200d above 50d
      Institutional flow Distributing
      -4% holders QoQ · +41 funds added
      Insider flow Distributing
      Net -$3.0M over 90 days · 100% sells
      Short interest Rising
      13.25% of float · ▲ +3.9% MoM · 16.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      330 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $52 Now $76 · 73% Range high $84
      vs 200-day avg +14% vs 50-day avg +18%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      aggregate advanced imaging procedural volumes growth 21.2% second quarter of 2026 —
      Annual Recurring Revenue (ARR) non-GAAP $105.5M second quarter of 2026 —
      Imaging Center Segment Adjusted EBITDA margin non-GAAP 16.1% second quarter of 2026 —
      same-center advanced imaging procedural volumes growth 9.6% second quarter of 2026 —
      Adjusted Diluted Loss Per Share non-GAAP -$0.28 first quarter of 2026 —
      CT volume (systemwide) 17.7% first quarter of 2026 —
      MRI volume (systemwide) 20.3% first quarter of 2026 —
      outpatient imaging centers 435 first quarter of 2026 —
      Overall same-center volume 2.4% first quarter of 2026 —
      Overall volume (systemwide) 10.1% first quarter of 2026 —
      PET/CT volume (systemwide) 35.2% first quarter of 2026 —
      same-center advanced imaging procedural volumes 8.2% first quarter of 2026 —
      Same-center CT volume 4.7% first quarter of 2026 —
      Same-center PET/CT volume 14.7% first quarter of 2026 —
      Total Company Adjusted Loss non-GAAP -$21.6M first quarter of 2026 —
      Adjusted Earnings Per Share non-GAAP $0.23 Q4 2025 —
      Adjusted EBITDA non-GAAP $300.2M FY2025 —
      Digital Health Adjusted EBITDA non-GAAP $15.5M FY2025 —
      MRI volume growth 15.8% Q4 2025 —
      Same-center overall volume growth 4.5% Q4 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Diagnostics & Research — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RDNT
      RadNet, Inc.
      this stock
      		$5.87B +5.9% +13.0% — 13.2%
      TMO
      Thermo Fisher Scientific Inc.
      		 $217.80B +5.9% +14.5% 31.7 1.3%
      DHR
      Danaher Corp /De/
      		 $147.41B -7.6% +8.5% 37.2 1.7%
      NTRA
      Natera, Inc.
      		 $45.29B +41.9% -2.8% — 3.0%
      IDXX
      Idexx Laboratories Inc /De
      		 $44.29B -16.9% +10.4% 39.5 2.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      330
      % held
      103.4%
      Net QoQ
      +4.1M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      401
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      10.4M
      Days to cover
      16.9d
      Change
      +388.1K sh
      View
      Short Volume
      Short vol %
      76%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      28.8K
      Value
      $1.8M
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      41.5%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$3.0M
      Buyers / Sellers
      0 / 3
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $2.0B
      Net income (FY)
      $-18.7M
      EPS diluted
      $-0.25
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 14, 2026
      This year
      14
      View
      Proposed Sales
      Value
      $145.4K
      Shares
      2.7K
      Filed
      Jun 18, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 10, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      RDNT -1.8% +27.6% +4.8% +18.4% +5.9%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY -1.4% +24.7% -6.8% +15.5% -6.9%
      Key facts CIK 790526 CUSIP 750491102 13F (30d) 302 filings 296 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)